AI-extracted from the 10-Q filed 2026-07-31 — Q2 FY2026 (quarter ended June 30, 2026). Every figure is machine-verified against the filing text on SEC EDGAR.
Corteva reported Q2 net sales of $6.4B, down 1% YoY, with operating EBITDA of $2.3B up from $2.2B, as cost actions and pricing gains offset volume declines ahead of intended business separation.
Biggest Revenue Drivers
Seed$7.6B+4% YoY
Pricing growth from top-technology demand and out-licensing, flat volume as higher soybean offset lower corn area and timing shifts.
Crop Protection$3.7B+3% YoY
Volume growth from new product demand offset by Latin America pricing pressure and North America channel timing.
Biggest Revenue Drivers
Total revenue: $11.3B+4% YoY
Seed$7.6B+4% YoY
Pricing growth from top-technology demand and out-licensing, flat volume as higher soybean offset lower corn area and timing shifts.
Crop Protection$3.7B+3% YoY
Volume growth from new product demand offset by Latin America pricing pressure and North America channel timing.
Largest Expense Items
Selling, general and administrative expenses$2.0B
Increase driven by unfavorable currency, higher bad debt, consulting fees and personnel costs, partially offset by lower legal support.
Research and development expense$729M
Increase in support of long-term investment plans driven by unfavorable currency and higher salaries, contract labor, and facilities costs.
Restructuring and asset related charges$141M
Severance and related costs under 2026 Restructuring Actions plus asset charges, decommissioning and contract terminations under Crop Protection Operations program.
Margins: Gross margin improved to 55% of net sales from 51% YoY, driven by royalty reductions and cost productivity actions. Operating EBITDA margin expanded approximately 100 basis points YoY to 33%, reflecting pricing/mix gains and cost actions that more than offset higher SG&A and R&D spending. Segment margins improved 230 bps in Seed and 110 bps in Crop Protection.
Watch Items from the Filing
Intended separation into independent Seed and Crop Protection companies announced October 2025; restructuring costs of $80M expected for 2026 Restructuring Actions and $750M–$815M aggregate for Crop Protection Operations program continuing through 2028.
FTC litigation settlement reached without admission of wrongdoing; multi-district litigation and Arkansas state attorney general case settlements reached, accrual established as of June 30, 2026, subject to court approval.
Legacy PFAS liabilities subject to MOU cost-sharing with Chemours and DuPont capped at $2B for Corteva (29% of shared costs); New Jersey Statewide Settlement of $875M aggregate (net present value ~$500M) over 25 years expected final court approval Q3 2026.
Discretionary pension contribution of $1.5B approved April 2026 ($1.1B paid June, $399M paid July), resulting in $50M tax charge; reflected in operating cash flow as $(3.3)B YTD despite $1.9B net income.
AI-extracted and verified against SEC EDGAR filing text. Not investment advice.
Johnson David PaulEVP, Chief Financial OfficerShares withheld for tax or exercise price · Sep 16, 2026
Johnson Jennifer AmySVP, Chief Legal OfficerShares withheld for tax or exercise price · Sep 15, 2026
Policinski Christopher J.Reporting ownerGrant or award · Jul 31, 2026
Giesselman Janet PlautReporting ownerGrant or award · Jul 31, 2026
Nayyar Nayaki RReporting ownerGrant or award · Jul 31, 2026
Engel Klaus AReporting ownerShares withheld for tax or exercise price · Apr 30, 2026
Lutz Marcos MReporting ownerShares withheld for tax or exercise price · Apr 30, 2026
Page Gregory RReporting ownerGrant or award · Apr 28, 2026
Congress trading in CTVA
12 transactions in CTVA reported by 10 members of Congress under the STOCK Act, most recent trade Sep 17, 2026. Reported transactions, not recommendations.
About Corteva, Inc. (CTVA): stock profile, AI score and financials
Corteva, Inc. (CTVA) stock profile, AI quality score, and SEC EDGAR financial data, a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores CTVA at 52.5/100 on a composite quality score built from its SEC filings, placing it at rank #1,465 of 2,925 stocks — the bottom half of the AI-ranked universe. CTVA scores in the top quartile across revenue scale (91.5). Areas of concern include revenue growth (33.6) and earnings quality (34.3), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Corteva, Inc. reports quarterly revenue of $6.4B, net income of $1.2B, an operating margin of 25.5%. Top institutional holders of CTVA by reported 13-F value include BlackRock, VANGUARD CAPITAL MANAGEMENT, Capital World Investors, based on the most recent SEC filings. CTVA trades on the NYSE exchange and files with the SEC under CIK 1755672. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CTVA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Corteva, Inc. directly from SEC EDGAR.